✦ LIBER ✦

Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a

✍ Scribed by Tsu-Yi Chao; Su-Huei Lee; Mary M. Chen; David H. Neustadt; Uzma A. Chaudhry; Lung T. Yam; Anthony J. Janckila

Book ID: 116350204
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 173 KB
Volume: 359
Category: Article
ISSN: 0009-8981
DOI: 10.1016/j.cccn.2005.03.039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of immunoassays for type-5 t

Development of immunoassays for type-5 tartrate-resistant acid phosphatase in human serum

✍ Shuichi Miyazaki; Makoto Igarashi; Atsuo Nagata; Yoshihiro Tominaga; Kenji Onode 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Serum tartrate-resistant acid phosphatas

Serum tartrate-resistant acid phosphatase isoform 5a (TRACP5a) as a potential risk marker in cardiovascular disease

✍ Anthony J. Janckila; Hseun-Fu Lin; Yi-Ying Wu; Chih-Hung Ku; Shih-Ping Yang; Wei 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 431 KB

Characterization of Serum Tartrate-Resis

Characterization of Serum Tartrate-Resistant Acid Phosphatase and Development of a Direct Two-Site Immunoassay

✍ Jussi M. Halleen; Teuvo A. Hentunen; Matti Karp; Sanna-Maria Käkönen; Kim Petter 📂 Article 📅 1998 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 107 KB

Tartrate-resistant acid phosphatase isof

Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis

✍ Tsu-Yi Chao; Yi-Ying Wu; Anthony J. Janckila 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Tartrate-resistant acid phosphatase isof

Tartrate-resistant acid phosphatase isoform 5b: A novel serum marker for monitoring bone disease in multiple myeloma

✍ Evangelos Terpos; Josu de la Fuente; Richard Szydlo; Evdoxia Hatjiharissi; Nora 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 80 KB

## Abstract Tartrate‐resistant acid phosphatase isoform‐5b (TRACP‐5b), a new marker reflecting osteoclast activity, and osteoprotegerin (OPG) were measured in 121 patients with multiple myeloma (MM) at diagnosis, and in 63 of them during pamidronate administration, to define their correlation with

Naphthol-ASBI Phosphate as a Preferred S

Naphthol-ASBI Phosphate as a Preferred Substrate for Tartrate-Resistant Acid Phosphatase Isoform 5b

✍ Anthony J. Janckila; Karen Takahashi; Susan Z. Sun; Lung T. Yam 📂 Article 📅 2001 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 507 KB